SF3B1 mutations, known as the most common spliceosome lesions in MDS cases [2], have been reported to be associated with superior survival and a specific MDS subtype, namely MDS with ringed sideroblasts (MDS-RS) [43]. Here, SF3B1 is linked to myelodysplastic syndrome.